Frederick Brown, PharmD

home / authors / frederick-brown-pharmd

Articles

Site Logo

The Expanding Role of New Medications in the Treatment of Type 2 Diabetes Mellitus

Kristen Harrison, MPH;Frederick Brown, PharmD;Brandeis Seymore, RPh;Anthony Palmieri, PharmD, MBA;Olga S. Matlin, PhD;Steven M. Kymes, PhD
August 21st 2013

We examined the prevalence of use and cost impact of DPP-4 inhibitors and GLP-1 receptor agonists in people with diabetes.

Read More

Site Logo

Conventional and Biologic Rheumatoid Arthritis Therapies: Utilization and Cost Trends

Osayi Akinbosoye, PhD, PAHM;Olga S. Matlin, PhD;Lisa Mostovoy, PharmD, MBA;Frederick Brown, PharmD;John A. Szychowski, AAS, BS
December 12th 2012

Based on American College of Rheumatology recommendations and novel emerging treatment options, the trend of increasing biologic use for rheumatoid arthritis is expected to continue.

Read More

Latest Updated Articles

Alzheimer and dementia clock drawing cognitive test -- Image credit: Jovana Milanko/Stocksy | stock.adobe.com
Published: September 20th 2024 | Updated: October 6th 2024
Mild Cognitive Impairment is Extremely Undiagnosed, Expert Says
This series features 5 KOLs.
Published: September 6th 2024 | Updated: October 6th 2024
Optimizing Pneumococcal Vaccination Efforts in High-Risk Patients
This series features 5 KOLs.
Published: September 13th 2024 | Updated: October 6th 2024
Closing Thoughts From The Panel On Pneumococcal Vaccination
This series features 5 KOLs.
Published: September 6th 2024 | Updated: October 6th 2024
Barriers to Administering Pneumococcal Vaccines and Best Practices for Overcoming Them
This series features 5 KOLs.
Published: August 30th 2024 | Updated: October 6th 2024
Future Considerations for Pneumococcal Vaccination
This series features 5 KOLs.
Published: August 30th 2024 | Updated: October 6th 2024
Insights on Conjugate Pneumococcal Vaccines